Bio-Path Holdings

BPTH

BPTH Bio-Path Holdings NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    BPTH Chart
    See on advanced chart >

    About

    Bio-path Holdings, Inc. is a development stage company with its lead cancer drug candidate, Liposomal Grb-2 , currently in clinical trials. The Company was founded with technology from The University of Texas, MD Anderson Cancer Center and is dedicated to...
    Read More
    • Highlight
      A biotechnology company that develops a portfolio of targeted nucleic acid cancer drugs
      • Industry
      Pharmaceuticals
    • Exchange
      NASDAQ
    • Listing Date
      03/10/2014
    • Established Date
      05/10/2007
    • Full-time Employees
      10
    • Address
      4710 Bellaire Boulevard Suite 210 Bellaire Texas 77401
    • Tel
      1-832-7421357
    • Website
      www.biopathholdings.com
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock